enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Osimertinib - Wikipedia

   en.wikipedia.org/wiki/Osimertinib

   Osimertinib, sold under the brand name Tagrisso, [6] is a medication used to treat non-small-cell lung carcinomas with specific mutations. [7] [8] It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.

3. Category:Drugs developed by AstraZeneca - Wikipedia

   en.wikipedia.org/wiki/Category:Drugs_developed...

   Pages in category "Drugs developed by AstraZeneca" The following 133 pages are in this category, out of 133 total. This list may not reflect recent changes. A.

4. Durvalumab - Wikipedia

   en.wikipedia.org/wiki/Durvalumab

   The US Food and Drug Administration (FDA) approved durvalumab for certain types of bladder, lung, and biliary tract cancer: [6] [13] [14]. Adults with locally advanced or metastatic urothelial carcinoma who either have disease progression during or following platinum-containing chemotherapy or have disease progression within twelve months of neoadjuvant or adjuvant treatment with platinum ...

5. AstraZeneca's Tagrisso-chemo combo given priority review in US

   www.aol.com/news/astrazenecas-tagrisso-chemo...

   (Reuters) -A combination of AstraZeneca's blockbuster cancer drug Tagrisso, with chemotherapy to treat a type of lung cancer, has been accepted and granted priority review by the U.S. Food and ...

6. US FDA approves AstraZeneca's non-small cell lung cancer ...

   www.aol.com/news/us-fda-approves-astrazenecas...

   The health regulator approved Imfinzi as an additional treatment after surgery in adult patients with non-small cell lung cancer. The drug is already approved in the U.S. for patients with a late ...

7. AstraZeneca's Imfinzi improves survival in late-stage lung ...

   www.aol.com/news/astrazenecas-imfinzi-shows...

   The U.S. Food and Drug Administration first approved the drug in 2017 to treat a type of bladder cancer. Imfinzi won approval for use in mid-stage non-small cell lung cancer a year later.

8. Savolitinib - Wikipedia

   en.wikipedia.org/wiki/Savolitinib

   It is being investigated for the treatment of cancer by AstraZeneca. [1] It is in phase II clinical trials for adenocarcinoma, non-small cell lung cancer, and renal cell carcinoma. [2] It has been given conditional approval for these indication in China. [3]

9. AstraZeneca's Imfinzi gets FDA priority review for type of ...

   www.aol.com/news/astrazenecas-imfinzi-gets-fda...

   AstraZeneca's application was based on positive late-stage data that showed the drug improved overall survival and progression-free survival in patients with a type of lung cancer, whose disease ...